The clinical trials ecosystem is complex involving clinical research sites, contract research organizations, and clinical trial participants. While the pandemic spurred digital transformation across the ecosystem, there is a huge variation in the scale of adoption and the extent of digital maturity by CROs and research sites mainly due to factors such as budget, strategic priorities, and ease of implementation. Consequently, at an ecosystem level, these efforts lead to poor trial design, delays in execution and most importantly low patient enrolment for new clinical studies as well as weak patient engagement for ongoing clinical trials.